Physician profile
Crystal Brown
NPI 1063494045
$5,065.72
in general payments reported to CMS, 2019-2025
42 companies · $588 in 2025
The $588 reported for 2025 was more than what 89% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,157 · 2022: $1,436 · 2023: $1,211 · 2024: $674 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,472.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,299.40 | 2021-2025 | |
| Amgen INC. | $688.86 | 2021-2025 | Repatha, Otezla, Aimovig |
| Novo Nordisk INC | $532.90 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $346.40 | 2021-2025 | Mounjaro, Jardiance, Reyvow |
| Pfizer INC. | $338.50 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $190.91 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $148.45 | 2022 | |
| Agile Therapeutics, INC. | $122.25 | 2021-2023 | Twirla |
| Teva Pharmaceuticals USA, INC. | $121.09 | 2021-2024 | Ajovy, Austedo Xr |
| Glaxosmithkline, LLC. | $110.65 | 2022-2025 | Trelegy Ellipta |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $101.50 | 2022-2025 | Caplyta |
| Axsome Therapeutics, INC. | $95.72 | 2023-2025 | Auvelity |
| Mayne Pharma Commercial LLC | $92.85 | 2021-2023 | |
| Hologic Sales and Service, LLC | $66.52 | 2022 | |
| Lundbeck LLC | $61.17 | 2025 | Vyepti |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.